
New drug combo shrinks tumors in most patients facing aggressive cancer type
The pancreatic cancer pill daraxonrasib shrank tumors in 60.7% of patients when paired with chemotherapy, with 8.2% seeing tumors vanish on scans.
This story was published by Fox News. Read the full article on their site.
Read the full story at foxnews.com(opens in a new tab)







